MX390725B - Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado. - Google Patents

Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado.

Info

Publication number
MX390725B
MX390725B MX2019010492A MX2019010492A MX390725B MX 390725 B MX390725 B MX 390725B MX 2019010492 A MX2019010492 A MX 2019010492A MX 2019010492 A MX2019010492 A MX 2019010492A MX 390725 B MX390725 B MX 390725B
Authority
MX
Mexico
Prior art keywords
methods
kits
platelet compositions
inactivated pathogen
preparing platelet
Prior art date
Application number
MX2019010492A
Other languages
English (en)
Other versions
MX2019010492A (es
Inventor
Anna Erickson
Betsy Donnelly
Naheed Mufti
Tovo David
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of MX2019010492A publication Critical patent/MX2019010492A/es
Publication of MX390725B publication Critical patent/MX390725B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0427—Platelets; Thrombocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a métodos para preparar composiciones de plaquetas con patógeno inactivado, así como conjuntos de procesamiento y composiciones relacionadas con esto.
MX2019010492A 2017-03-03 2018-03-02 Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado. MX390725B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762467021P 2017-03-03 2017-03-03
US201862622127P 2018-01-25 2018-01-25
PCT/US2018/020745 WO2018161020A1 (en) 2017-03-03 2018-03-02 Kits and methods for preparing pathogen-inactivated platelet compositions

Publications (2)

Publication Number Publication Date
MX2019010492A MX2019010492A (es) 2019-11-25
MX390725B true MX390725B (es) 2025-03-21

Family

ID=61692101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010492A MX390725B (es) 2017-03-03 2018-03-02 Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado.

Country Status (9)

Country Link
US (2) US11235090B2 (es)
EP (2) EP3589297A1 (es)
CN (1) CN110573169B (es)
AU (1) AU2018227586B2 (es)
BR (1) BR112019018273A2 (es)
CA (1) CA3055203A1 (es)
MX (1) MX390725B (es)
WO (1) WO2018161020A1 (es)
ZA (1) ZA201905895B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2990864A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
WO2017070619A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
AU2017382449B2 (en) 2016-12-23 2024-10-24 Cerus Corporation Systems and methods for testing and screening using compound bound substrates
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
WO2019133929A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
US12514944B2 (en) 2019-06-22 2026-01-06 Cerus Corporation Systems and methods for implementing treatment of biological fluids
WO2020263759A2 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
AU2020308035B2 (en) 2019-06-28 2025-07-24 Cerus Corporation System and methods for implementing a biological fluid treatment device

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5167656A (en) 1991-01-22 1992-12-01 Baxter International Inc. Blood container having lay-flat sample reservoir
EP0544895B1 (en) 1991-06-21 1997-08-27 Baxter International Inc. Method for inactivating pathogens in a body fluid
US5709991A (en) 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
US5459030A (en) 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5288605A (en) 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU4677993A (en) 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU4107396A (en) 1992-03-02 1996-06-06 Cerus Corporation Synthetic media for blood components
US5618662A (en) 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5712085A (en) 1993-06-28 1998-01-27 Cerus Corporation 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5593823A (en) 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
EP0727938B1 (en) 1993-11-10 2003-06-18 Cerus Corporation Device and method for photoactivation
AU691672B2 (en) 1994-09-22 1998-05-21 Baxter International Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
US20020192632A1 (en) 1995-06-07 2002-12-19 Hei Derek J. Method and devices for the removal of psoralens from blood products
CA2199731A1 (en) 1995-06-07 1996-12-19 Susan Wollowitz Treating red blood cell solutions with anti-viral agents
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
ATE451445T1 (de) 1995-06-07 2009-12-15 Cerus Corp Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
WO1996039820A1 (en) 1995-06-07 1996-12-19 Cerus Corporation Methods of inactivating leukocytes and inhibiting cytokine production in blood products
WO1997021346A1 (en) 1995-12-14 1997-06-19 Cerus Corporation Inactivation of non-enveloped virus
US20020115585A1 (en) 1996-06-07 2002-08-22 Hei Derek J. Method and devices for the removal of psoralens from blood products
US6190855B1 (en) 1996-10-28 2001-02-20 Baxter International Inc. Systems and methods for removing viral agents from blood
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US6093725A (en) 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
DE69827770T2 (de) 1997-01-06 2006-03-02 Cerus Corp., Concord Adsorbentien und geräte zur verminderung von kleinen organischen verbindungen aus blutprodukten
US6514987B1 (en) 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
EP1021414B1 (en) 1997-01-06 2003-06-18 Cerus Corporation Frangible compounds for pathogen inactivation
EP1005531A2 (en) 1997-07-21 2000-06-07 Cerus Corporation Method of treating leukocytes, leukocyte compositions and methods of use thereof
EP1032265B1 (en) 1997-11-20 2003-10-29 Cerus Corporation New psoralens for pathogen inactivation
AU759966C (en) 1998-01-06 2004-02-12 Cerus Corporation Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
CN1203900C (zh) 1998-01-06 2005-06-01 塞鲁斯公司 用于淬灭生物材料中病原体灭活剂的方法
CA2332314A1 (en) 1998-06-11 1999-12-16 Cerus Corporation Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
US6099734A (en) 1998-07-08 2000-08-08 Baxter International Inc. Apparatus, membranes and methods for removing organic compounds from a biological fluid
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6364864B1 (en) * 1999-06-03 2002-04-02 Baxter International Inc. Plastic containers having inner pouches and methods for making such containers
US7445756B2 (en) 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US7025877B1 (en) 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
WO2001091775A2 (en) 2000-05-31 2001-12-06 Cerus Corporation Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
JP4412441B2 (ja) 2000-07-11 2010-02-10 日本電気株式会社 液晶表示装置
US20030113704A1 (en) 2000-12-21 2003-06-19 Cerus Corporation Methods for inactivation of pathogens in biological materials
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7264608B2 (en) 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
US6936413B1 (en) 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US20030207247A1 (en) 2001-12-05 2003-11-06 Cerus Corporation Preparation of red blood cells having reduced immunogenicity
CN1646147A (zh) 2002-02-06 2005-07-27 约翰斯霍普金斯医学院 用于将系统性免疫应答靶向于特定器官或组织的方法和组合物
CA2477946A1 (en) 2002-03-14 2003-09-25 Baxter International Inc. Compound removal device
AU2003221787A1 (en) 2002-04-26 2003-11-10 Gambro, Inc. Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
WO2004006837A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Mesothelin vaccines and model systems
AU2003298827A1 (en) 2002-12-04 2004-06-23 Cerus Corporation Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
WO2004084936A2 (en) 2003-02-06 2004-10-07 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
JP4545151B2 (ja) 2003-02-06 2010-09-15 シーラス コーポレイション 非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
US7534348B2 (en) 2003-09-12 2009-05-19 Fenwal, Inc. Flow-through removal device and system using such device
EP1682173A4 (en) 2003-10-15 2007-10-31 Medimmune Inc EPHA2 VACCINE ON LISTERIA BASE
WO2005067460A2 (en) 2003-12-24 2005-07-28 Medimmune, Inc. Epha2 vaccines
AU2004314347B2 (en) 2003-12-24 2011-05-19 Aduro Biotech, Inc. Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
WO2005092372A2 (en) 2004-02-06 2005-10-06 Cerus Corporation Modified bacillus anthracis vaccine compositions and methods of use thereof
US20070031457A1 (en) 2004-02-06 2007-02-08 Dubensky Thomas W Jr Modified Bacillus anthracis, vaccine compositions and methods of use thereof
US8296071B2 (en) 2004-03-15 2012-10-23 Terumo Bct Biotechnologies, Llc Methods for uniformly treating biological samples with electromagnetic radiation
EP1838355B1 (en) 2004-10-29 2013-08-14 Cerus Corporation Improved quenching methods for red blood cell inactivation process
WO2007022520A2 (en) 2005-08-19 2007-02-22 Cerus Corporation Antibody-mediated enhancement of immune response
JP2009504786A (ja) 2005-08-19 2009-02-05 シーラス コーポレイション リステリア属誘導型免疫漸増および活性化、ならびにその使用方法
US20070207171A1 (en) 2006-03-01 2007-09-06 Cerus Corporation Engineered listeria and methods of use thereof
WO2007117371A2 (en) 2006-03-01 2007-10-18 Anza Therapeutics, Inc. Engineered listeria and methods of use thereof
US7935804B2 (en) 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
WO2007103261A2 (en) 2006-03-01 2007-09-13 Medimmune, Inc. Listeria-based epha2 immunogenic compositions
JP5347135B2 (ja) 2006-03-01 2013-11-20 アドゥロ バイオテック 遺伝子工学操作されたｌｉｓｔｅｒｉａおよびその使用方法
CA2720824C (en) 2008-04-09 2021-09-14 Cerus Corporation Improved quenching methods for red blood cell pathogen inactivation
US20150056604A1 (en) * 2009-06-15 2015-02-26 Biovec Transfusion, Llc Compositions and methods for preserving platelet function
US8877060B2 (en) 2010-11-23 2014-11-04 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
FR2963737B1 (fr) 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
US20170304363A1 (en) 2014-10-10 2017-10-26 Cerus Corporation Compositions and methods for treating viral hemorrhagic fever
US20180185484A1 (en) 2015-01-16 2018-07-05 Cerus Corporation Preparation and use of platelet products
CA2990864A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
WO2017070619A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
US20200078406A1 (en) 2016-01-07 2020-03-12 Cerus Corporation Systems and methods for preparation of platelets
AU2017382449B2 (en) 2016-12-23 2024-10-24 Cerus Corporation Systems and methods for testing and screening using compound bound substrates
US20190321407A1 (en) 2016-12-31 2019-10-24 Cerus Corporation Compositions and methods for preparation of red blood cells
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
EP3684774A1 (en) 2017-09-20 2020-07-29 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
WO2019133929A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
US20220031917A1 (en) 2018-09-20 2022-02-03 Cerus Corporation Methods and kits for preparing pathogen-inactivated whole blood
US12514944B2 (en) 2019-06-22 2026-01-06 Cerus Corporation Systems and methods for implementing treatment of biological fluids
WO2020263759A2 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
AU2020308035B2 (en) 2019-06-28 2025-07-24 Cerus Corporation System and methods for implementing a biological fluid treatment device

Also Published As

Publication number Publication date
US20180289873A1 (en) 2018-10-11
US20220105250A1 (en) 2022-04-07
CA3055203A1 (en) 2018-09-07
EP4606379A3 (en) 2025-11-19
CN110573169B (zh) 2024-10-01
US11235090B2 (en) 2022-02-01
WO2018161020A1 (en) 2018-09-07
EP3589297A1 (en) 2020-01-08
US12064537B2 (en) 2024-08-20
CN110573169A (zh) 2019-12-13
AU2018227586B2 (en) 2023-12-21
EP4606379A2 (en) 2025-08-27
BR112019018273A2 (pt) 2020-07-14
MX2019010492A (es) 2019-11-25
ZA201905895B (en) 2025-01-29
AU2018227586A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
CL2019000424A1 (es) Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.
CY1124663T1 (el) Αντιιικα παραγωγα ν4-υδροξυκυτιδινης
MX390725B (es) Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado.
BR112017003414A2 (pt) composições compreendendo caseína e métodos para produzir as mesmas
BR112019012342A2 (pt) anticorpos il-11
MX2019007021A (es) Anticuerpos il-11ra.
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
TR2021016542A2 (tr) Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.
MX2018006767A (es) Composiciones y metodos para oncologia inmunologica.
EA201890493A1 (ru) РЕПРЕССОРЫ Htt И ИХ ПРИМЕНЕНИЕ
MX2018010484A (es) Métodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cáncer.
EA201691991A1 (ru) Мультиспецифические антитела
TR201810635T4 (tr) Anti-jagged1 antikorları ve kullanım yöntemleri.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
LT3638271T (lt) Kompozicijos, apimančios bakterines padermes
JOP20190164B1 (ar) تركيبات وطرق لعلاج داء فاربر
EA201591709A1 (ru) 5-бром-индирубины
MX394471B (es) Composiciones y métodos para desgomar aceite.
CL2021002836A1 (es) Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos (divisional de la solicitud n° 201900424)
CL2019000555S1 (es) Licuadora.
EA201990505A1 (ru) Анти-tigit антитела, анти-pvrig антитела и их комбинации
UA114708U (uk) Тяговий привід електробуса
GEAP201814364A (en) Radial-squeezing machine
TN2014000384A1 (fr) نظام صوتي ذكي وآمن
TN2014000522A1 (fr) لوح مدرسي بوجهين